A

APLM

APLM

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
50%Neutral
Buy/Sell Ratio100% buys
BearishBullish
APLM Live QuoteReal-time
$16.69
$4.90(-22.70%)1M
Day Range$16.68 – $16.69
Open$16.68
Previous Close$16.45
Volume979
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$48.65M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.25
Price to Book8.1
Dividend Yield0.65%
Beta (Volatility)1.56
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $16.69 (26%)
Low: $12.58High: $28.29
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$2.00-98.7% upside

Insider Buys

1

$8.25M

Insider Sales

0

$0

Total Volume

$8.25M

2 transactions

Net Activity

+$8.25M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

1 buys1 sells

$2.73B total

Trading History
APLM insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 14, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell136.2K$20000.00$2.72B

Aug 14, 2026

3 months ago

Multiple Insiders

3 Insiders

Insider
Buy583.3K$14.14$8.25M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
APLM Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

APLM has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for APLM

Over the last 90 days, corporate insiders at APLM (APLM) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $8.25M.

The net insider activity for APLM shows a net buying bias of $8.25M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 136.2K shares valued at $2.72B on Aug 14, 2026.

Live Market News & Developments
Aggregated real-time headlines for APLM (APLM)
6 updates

Director directly holds 2,000 shares after a stock award vests at Apollomics (APLM).

Stock Titan2d ago

Trading the Move, Not the Narrative: (APLM) Edition

Stock Traders Daily4d ago

Apollomics Inc. (APLM) Stock Price History & Data

Traders Union6d ago

APLM Forecast — Price Target — Prediction for 2027

TradingView147d ago

Insiders Of Apollomics Are Up 69% On Their US$7.95m Purchase

Simply Wall St93d ago

Apollomics COO Chen Yi-Kuei buys $300,000 in shares

Investing.com95d ago

FAQs About APLM Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for APLM.

Based on SEC Form 4 disclosures, the Insider Confidence Score for APLM is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for APLM is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.